David Bernardo

About David Bernardo

David Bernardo, With an exceptional h-index of 39 and a recent h-index of 29 (since 2020), a distinguished researcher at Universidad de Valladolid, specializes in the field of Human Mucosal Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatment

A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients

Plasma levels of intestinal fatty-acid binding protein (I-FABP), abdominal distension and hydrogen concentration after lactitol small intestinal bacterial overgrowth (SIBO) test

62-EFECTO EX VIVO DE INFLIXIMAB EN LOS NIVELES DE EXPRESIÓN DE LOS LONG NON-CODING RNAS EN LA ENFERMEDAD DE CROHN

MIF is a common genetic determinant of COVID-19 symptomatic infection and severity

P058 Immunological effects of hepatitis B virus vaccination in inflammatory bowel disease patients

P044 Ex vivo effects of infliximab on the long non-coding RNAs expression levels in Crohn′ s disease

David Bernardo Information

University

Position

Institute of Biology and Molecular Genetics (IBGM). -CSIC

Citations(all)

6918

Citations(since 2020)

4871

Cited By

2084

hIndex(all)

39

hIndex(since 2020)

29

i10Index(all)

83

i10Index(since 2020)

64

Email

University Profile Page

Google Scholar

David Bernardo Skills & Research Interests

Human Mucosal Immunology

Top articles of David Bernardo

Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatment

medRxiv

2023

David Bernardo
David Bernardo

H-Index: 22

A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

Scientific Reports

2024/2/6

Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients

Inflammatory Bowel Diseases

2024/2/1

Plasma levels of intestinal fatty-acid binding protein (I-FABP), abdominal distension and hydrogen concentration after lactitol small intestinal bacterial overgrowth (SIBO) test

Revista Espanola de Enfermedades Digestivas

2023/3/17

62-EFECTO EX VIVO DE INFLIXIMAB EN LOS NIVELES DE EXPRESIÓN DE LOS LONG NON-CODING RNAS EN LA ENFERMEDAD DE CROHN

Gastroenterología y Hepatología

2023/3/1

Lorena Ortega
Lorena Ortega

H-Index: 6

David Bernardo
David Bernardo

H-Index: 22

MIF is a common genetic determinant of COVID-19 symptomatic infection and severity

QJM: An International Journal of Medicine

2023/3/1

P058 Immunological effects of hepatitis B virus vaccination in inflammatory bowel disease patients

Journal of Crohn's and Colitis

2023/2/1

P044 Ex vivo effects of infliximab on the long non-coding RNAs expression levels in Crohn′ s disease

Journal of Crohn's and Colitis

2023/2/1

Study and isolation of human intestinal dendritic cell and macrophage subsets

2023/1/1

Eduardo Arranz
Eduardo Arranz

H-Index: 15

David Bernardo
David Bernardo

H-Index: 22

Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes

International journal of molecular sciences

2023/8/30

Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress

2023

Women’s Birth Preparedness and Complication Readiness in Nigeria: A Systematic Review and Meta-Analysis

2023/6/20

Top-of-the-art cytometry as a novel tool to aid in lung cancer immunotherapy

Translational Lung Cancer Research

2023/5/5

David Bernardo
David Bernardo

H-Index: 22

Unbiased spectral cytometry immunome characterization predicts COVID-19 mRNA vaccine failure in older adults and patients with lymphoid malignancies

medRxiv

2023/4/10

Eduardo Arranz
Eduardo Arranz

H-Index: 15

David Bernardo
David Bernardo

H-Index: 22

Metabolomics study of COVID-19 patients in four different clinical stages

Scientific reports

2022/1/31

David Bernardo
David Bernardo

H-Index: 22

P027 Effects of anti-TNF and anti-α4β7 drugs on circulating monocytes migratory capacity in inflammatory bowel disease

Journal of Crohn's and Colitis

2022/1/1

P067 Human intestinal CD103+ SIRPα+ conventional dendritic cells from patients with Crohn′ s disease prime IL-17+ T-cells

Journal of Crohn's and Colitis

2022/1/1

See List of Professors in David Bernardo University(Universidad de Valladolid)

Co-Authors

academic-engine